Sign in
CompletedNo phase

Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients

Key facts

Who runs it
Eye & ENT Hospital of Fudan University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
363 people enrolled
Started
28 Oct 2024
Ended
11 Feb 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Personalized 40 Hz Broadband Stimulation
  • 40 Hz Pure Tone Stimulation
  • Continuous Broadband Noise
Record updated
27 October 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Diagnosed with subjective tinnitus
  • Chronic tinnitus: tinnitus course ≥ 1 month
  • Normal middle ear function
  • The average hearing threshold (defined as mean of 0.5, 1, 2, and 4 kHz) of the unaffected ear < 60 dB
  • Tinnitus can be heard under normal circumstances
  • Subjects are able to understand the purpose of the study, volunteer to participate and cooperate with the instructors to complete the experiment, and be willing to sign the informed consent

Who cannot take part

  • Severe psychiatric disorders
  • Acute phase tinnitus
  • Fluctuating tinnitus loudness
  • Inability to complete tinnitus testing
  • Fluctuating or retrocochlear hearing loss
  • Conductive hearing loss
  • Currently participating in other research projects that may affect tinnitus
  • Subjects who are not considered suitable for this clinical trial by the researchers

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Tinnitus affects 10-15% of adults and is frequently associated with impaired quality of life, anxiety, and sleep disturbance. Conventional sound therapies based on continuous masking provide inconsistent and short-lived relief, and the neural mechanisms underlying residual inhibition (RI) remain unclear.

Read full original descriptionShow less

This study aims to determine whether 40 Hz burst stimulation with high-frequency carriers can achieve longer-lasting RI than continuous sound, and to explore its underlying neural mechanisms using EEG.

The 3 groups in the trial

  • Personalized 40 Hz Broadband StimulationTreatment being tested

    Participants receive personalized broadband acoustic stimulation modulated at 40 Hz. An adaptive equalization algorithm, based on individual and population residual inhibition (RI) responses, is used to weight frequency components across 125 Hz-12 kHz.

  • 40 Hz Pure Tone StimulationTreatment being tested

    Participants receive pure tone stimulation at the individually optimized carrier frequency identified in earlier phases, amplitude-modulated at 40 Hz.

  • Continuous Broadband NoiseExisting treatment, for comparison

    Participants receive continuous broadband noise stimulation without 40 Hz modulation.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Reversible Suppression of a Phantom Percept is Associated With State-dependent Cortical Network Reconfiguration
Record updated
27 October 2026